Medication
Pharmaceutical compound
Roflurane (INN, USAN; development code DA-893) is a halocarbon drug which was investigated as an inhalational anesthetic but was never marketed.[1][2][3][4]
See also
References
- ↑ United States Adopted Names (USAN). United States Pharmacopeial Convention. 1968.
- ↑ Dissertation Abstracts. University Microfilms. May 1964.
- ↑ Reports on the Progress of Applied Chemistry. Society of Chemical Industry. 1963.
- ↑ Hudlický M (1976). Chemistry of organic fluorine compounds: a laboratory manual with comprehensive literature coverage. Ellis Horwood Limited. ISBN 978-0-470-41835-2.
| Inhalational | |||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Injection |
| ||||||||||||||
| |||||||||||||||
